Tag Archives: Ariad v. Lilly

A Look Back at the Roots of the Thorny WDR Problem

As the date for oral argument looms in Ariad v. Lilly, as does an en banc decision as to the existence and/or the role of the written description requirement (WDR) in Section 112, I thought it would be worthwhile to … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , | 2 Comments

TALKING WRITTEN DESCRIPTION REQUIREMENT BLUES – ARIAD WOBBLES

On October 5, 2009, Ariad filed a 60 page brief (not counting attached appendices) with the Federal Circuit in support of its appeal in Ariad v. Lilly. (Attached below.) As you will recall from my post of August 24th, the … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , | Leave a comment

NATURE/BIOTECHNOLOGY SUMMARIZES ARIAD DECISION

A recent article by Ken Garber in Nature/Biotechnology, 27, 494 (June 2009) summarizes the recent Federal Circuit decision invalidating the claims-in-suit in Ariad v. Lilly for failure to meet the WDR. (See my post of April 13, 2009 “Federal Circuit … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , | Leave a comment